AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 7878390
Drug: Desmopressin spray
RxNorm normalized name: desmopressin Nasal Spray
DrugBank: Desmopressin (DB00035)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Desmopressin spray
Trial: 21592879
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (Amlodipine/valsartan)
Trial: 31402718
Drug: Ibuprofen (IBU)
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen (IBU) 400 mg
Trial: 22408266
Drug: Discontinued antidepressant
RxNorm normalized name: guaifenesin / hydrocodone bitartrate / phenylephrine hydrochloride Oral Solution [Entex HC Discontinued]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinued antidepressant treatment (63 patients)
Trial: 3033444
Drug: Oestradiol valerate
RxNorm normalized name: Estradiol Valerate
DrugBank: Estradiol valerate (DB13956)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oestradiol valerate (EV) 2 mg/day for 21 days + NET
Trial: 3033444
Drug: Oestriol (E3)
RxNorm normalized name: Oestriol
DrugBank: Estriol (DB04573)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oestriol (E3) 2‐4 mg/day
Trial: 6349744
Drug: Radical radiotherapy
RxNorm normalized name: Campsis radicans flower extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radical radiotherapy followed by chemotherapy using doxorubicin (Adriamycin) and 5-fluorouracil
Trial: 22159966
Drug: Topical Mitomycin
RxNorm normalized name: Mitomycin
DrugBank: Mitomycin (DB00305)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical Mitomycin C
Trial: 17785082
Drug: 10-hydroxy-camptothecin (10-HCPT)
RxNorm normalized name: 9-[(dimethylamino)methyl]-10-hydroxy-(4S)-camptothecin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-hydroxy-camptothecin (10-HCPT) 4 mg/m2 with 5-fluoro-uracil (5-FU) 425 mg/m2 and leucovorin (LV) 20 mg/m2
Trial: 17785082
Drug: 10-hydroxy-camptothecin (10-HCPT)
RxNorm normalized name: 9-[(dimethylamino)methyl]-10-hydroxy-(4S)-camptothecin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-hydroxy-camptothecin (10-HCPT) 6 mg/m2 with 5-fluoro-uracil (5-FU) 425 mg/m2 and leucovorin (LV) 20 mg/m2
Trial: 26521571
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy of acupuncture at head points and seed-pressure at ear points
Trial: 8613890
Drug: Wheat fiber-supplemented
RxNorm normalized name: FIBERMED HIGH-FIBER SUPPLEMENT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wheat fiber-supplemented diet (40 g dietary fiber)
Trial: 26002049
Drug: Enalapril 20
RxNorm normalized name: enalapril 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 20 mg/day
Trial: 19834314
Drug: Polyphenol-rich antioxidant
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polyphenol-rich antioxidant supplement containing pomegranate extract, green tea extract, and ascorbic acid
Trial: 16363622
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of 18FDG-PET and bone scintigraphy
Trial: 12398236
Drug: Post-breakfast C-peptide
RxNorm normalized name: peptide-T
DrugBank: Peptide-T (DB19279)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post-breakfast C-peptide levels <= 0.8 nmol/l
Trial: 9884259
Drug: Oral acyclovir
RxNorm normalized name: Acyclovir
DrugBank: Acyclovir (DB00787)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral acyclovir (800 mg q.i.d.)
Trial: 9884259
Drug: Oral ganciclovir
RxNorm normalized name: Ganciclovir
DrugBank: Ganciclovir (DB01004)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ganciclovir (1000 mg t.i.d.)
Trial: 9884259
Drug: Oral acyclovir
RxNorm normalized name: Acyclovir
DrugBank: Acyclovir (DB00787)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral acyclovir vs. ganciclovir in D+R- patients
Trial: 9884259
Drug: Oral acyclovir
RxNorm normalized name: Acyclovir
DrugBank: Acyclovir (DB00787)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral acyclovir vs. ganciclovir in D+R+ patients
Trial: 22905856
Drug: Dolutegravir (DTG)
DrugBank: Dolutegravir (DB08930)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dolutegravir (DTG) 50 mg twice daily
Trial: 31175909
Drug: brodalumab 210
RxNorm normalized name: BRODALUMAB 210MG/1.5ML INJ 1.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: brodalumab 210 mg every 2 weeks
Trial: 15914987
Drug: Fluoride gel
RxNorm normalized name: Sodium Fluoride Gel
DrugBank: Sodium fluorophosphate (DB09484)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoride gel application
Trial: 8836612
Drug: Dextromethorphan 240
RxNorm normalized name: Dextromethorphan
DrugBank: Dextromethorphan (DB00514)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dextromethorphan 240 mg
Trial: 6662157
Drug: Prizidilol hydrochloride
RxNorm normalized name: Chlorpromazine Hydrochloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prizidilol hydrochloride 400‐700 mg once daily (mean 612 mg/day)
Trial: 17996212
Drug: Topical levofloxacin
RxNorm normalized name: Levofloxacin
DrugBank: Levofloxacin (DB01137)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical levofloxacin (0.5%) four times on the day before surgery + Povidone-iodine (PVI) irrigation
Trial: 11195900
Drug: Ultrasound therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound therapy with irradiation and heating
Trial: 11195900
Drug: Ultrasound therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound therapy without irradiation or heating (placebo group)
Trial: 9028977
Drug: Extrapleural intercostal
RxNorm normalized name: INTRAPLEURAL MEDICATIONS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extrapleural intercostal nerve block with intermittent low-dose bupivacaine
Trial: 1504638
Drug: Intermittent nicotine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intermittent nicotine (15 mu/kg) via nasal spray
Trial: 10464846
Drug: Oral bambuterol
RxNorm normalized name: bambuterol
DrugBank: Bambuterol (DB01408)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral bambuterol (20 mg nocte)
Trial: 31200641
Drug: Continuous epidural
RxNorm normalized name: ACCU-BLOC PERIFIX CONTINUOUS EPIDURAL ANESTHESIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous epidural infusion (CEI)
Trial: 26652051
Drug: Progesterone treatment
RxNorm normalized name: Progesterone
DrugBank: Progesterone (DB00396)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Progesterone treatment
Trial: 20504097
Drug: No hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No hormone therapy (control)
Trial: 9706245
Drug: Ganciclovir alone
RxNorm normalized name: Ganciclovir
DrugBank: Ganciclovir (DB01004)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ganciclovir alone or in combination with foscarnet
Trial: 9508190
Drug: Cisplatin (CDDP)
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin (CDDP) 100 mg/m2 on day 1 and 5‐FU 1,000 mg/m2/d by continuous infusion for 96 hours (days 1 to 4) without interferon alfa-2b (arm A)
Trial: 24326395
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg oral risperidone
Trial: 18054465
Drug: Moxifloxacin 400
RxNorm normalized name: moxifloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxifloxacin 400 mg single oral dose
Trial: 23114033
Drug: Fluoride treatment
RxNorm normalized name: 60 Second 1.23% Fluoride Treatment Dental Gel
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluoride treatment
Trial: 15199083
Drug: Clozapine alone
RxNorm normalized name: Clozapine
DrugBank: Clozapine (DB00363)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clozapine alone (10 mg single dose)
Trial: 24716775
Drug: Self-administered paper
RxNorm normalized name: paper birch pollen extract
DrugBank: Betula papyrifera pollen (DB10831)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-administered paper surveys
Trial: 15477366
Drug: Testosterone enanthate
RxNorm normalized name: Testosterone Enanthate
DrugBank: Testosterone enanthate (DB13944)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone enanthate (TE) 100 mg weekly intramuscularly plus levonorgestrel (LNG) 62.5 or 31.25 microg orally daily
Trial: 1936480
Drug: Intensified insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensified insulin therapy (6 weeks of intermediate and short‐acting insulin 3 times daily)
Trial: 17014060
Drug: Protease inhibitors
RxNorm normalized name: Protease inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protease inhibitors (PIs)
Trial: 9443470
Drug: 10 mg/d
RxNorm normalized name: Arixtra 10 mg/dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg/d donepezil
Trial: 23284983
Drug: Male drinkers
RxNorm normalized name: monofluorophosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Male drinkers consuming ≥ 90 g/d (≈8 drinks/d)
Trial: 29889693
Drug: Sequential administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sequential administration of pneumococcal conjugate vaccine followed by PPS23 vaccine
Trial: 12021498
Drug: Influenza vaccines
RxNorm normalized name: Influenza vaccines
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Influenza vaccines
Trial: 10951278
Drug: Ex vivo
RxNorm normalized name: Allogeneic ex vivo expanded umbilical cord blood cells
DrugBank: Carlecortemcel-L (DB17186)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ex vivo UV exposure of human skin with a single dose of 200 mJ/cm2
Trial: 15013654
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (both drug and behavioral therapy)
Trial: 21982055
Drug: Pimecrolimus cream
RxNorm normalized name: Pimecrolimus
DrugBank: Pimecrolimus (DB00337)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pimecrolimus cream
Trial: 28028369
Drug: Pegylated interferon
RxNorm normalized name: Pegylated interferon alfa-2a
DrugBank: Peginterferon alfa-2a (DB00008)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pegylated interferon α-2a (0.5 mg daily for 48 weeks)
Trial: 11315837
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (metformin + GLP-1)
Trial: 15034215
Drug: Raltitrexed 3
RxNorm normalized name: raltitrexed
DrugBank: Raltitrexed (DB00293)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raltitrexed 3 mg/m2 iv on day 1 and oxaliplatin 70 mg/m2 iv on day 1 and day 8 every 3 weeks
Trial: 3356109
Drug: Saline solutions
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solutions (osmolarity range 77-1232 mosmol/l)
Trial: 31808297
Drug: Platform-switched implants
RxNorm normalized name: Witch Hazel
DrugBank: Witch hazel (DB11111)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Platform-switched implants (Group I)
Trial: 31808297
Drug: Platform-switched implants
RxNorm normalized name: Witch Hazel
DrugBank: Witch hazel (DB11111)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Platform-switched implants (Group II)
Trial: 1504110
Drug: Alprazolam treatment
RxNorm normalized name: Alprazolam
DrugBank: Alprazolam (DB00404)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alprazolam treatment
Trial: 24829
Drug: Corticosteroids combined
RxNorm normalized name: combinations of corticosteroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroids combined with an adrenergic beta-stimulant
Trial: 2478368
Drug: Combined drug
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined drug therapy (choline-piracetam)
Trial: 11701449
Drug: Growth Hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth Hormone (GH) administration for 6 days
Trial: 24576827
Drug: Iodine supplementation
RxNorm normalized name: Iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Iodine supplementation (1 μg/kg/day)
Trial: 22876725
Drug: Soy protein
RxNorm normalized name: Soy Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy protein based supplement (G1)
Trial: 26965560
Drug: Solifenacin 10
RxNorm normalized name: solifenacin 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solifenacin 10 mg
Trial: 21716130
Drug: Dexlansoprazole MR
RxNorm normalized name: Dexlansoprazole
DrugBank: Dexlansoprazole (DB05351)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dexlansoprazole MR 30 mg QD for 7 days
Trial: 21716130
Drug: Dexlansoprazole MR
RxNorm normalized name: Dexlansoprazole
DrugBank: Dexlansoprazole (DB05351)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dexlansoprazole MR 60 mg QD for 7 days
Trial: 26029985
Drug: Denosumab 60
RxNorm normalized name: denosumab 60 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Denosumab 60 mg subcutaneously every 6 months for 36 months
Trial: 2709206
Drug: Nonantibiotic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonantibiotic treatment (Group II)
Trial: 2858619
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (azathioprine and prednisolone)
Trial: 8866625
Drug: Nebulised fenoterol
RxNorm normalized name: fenoterol
DrugBank: Fenoterol (DB01288)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulised fenoterol (2 mg)
Trial: 25269598
Drug: Ceftriaxone 2
RxNorm normalized name: ceftriaxone 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone 2 g every 24 hours intravenously for 4 days in addition to standard stroke-unit care
Trial: 17892635
Drug: Transdermal patch
RxNorm normalized name: TRANSDERMAL PATCH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal patch containing rivastigmine (Exelon)
Trial: 17892635
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of AD therapies
Trial: 11397621
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of ceftazidime (3 g/day)
Trial: 18394014
Drug: Conventional-dose HT
RxNorm normalized name: 5-HT
DrugBank: Serotonin (DB08839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional-dose HT (2 mg of 17beta-estradiol and 1 mg of NETA)
Trial: 10985613
Drug: Metronidazole 250
RxNorm normalized name: metronidazole 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole 250 mg 3 times/d
Trial: 3882657
Drug: Erythromycin stearate,
RxNorm normalized name: Erythromycin Stearate, stearate 250 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin stearate, 1.5 g
Trial: 10634375
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human GH treatment (0.15 IU/kg x day for 1 week)
Trial: 25619124
Drug: Centchroman 30mg
DrugBank: Ormeloxifene (DB13310)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Centchroman 30mg daily for 12 weeks
Trial: 28193605
Drug: Intensive SBP
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive SBP treatment (goal of <120 mm Hg)
Trial: 10695392
Drug: Low-dose prednisolone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose prednisolone (0.5 mg/kg/day)
Trial: 16969498
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy plus cystectomy
Trial: 11240946
Drug: Low-dose fluticasone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose fluticasone propionate (FP) 88 microg (2 puffs of 44 microg) twice daily
Trial: 9252847
Drug: Secretin stimulation
RxNorm normalized name: Secretin
DrugBank: Secretin human (DB09532)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Secretin stimulation (1 IU/kg intravenous bolus)
Trial: 12621276
Drug: Animal-assisted therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Animal-assisted therapy (AAT) for 15 minutes
Trial: 27914241
Drug: Trebananib plus
RxNorm normalized name: Trebananib
DrugBank: Trebananib (DB12056)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trebananib plus pegylated liposomal doxorubicin (PLD) 50 mg/m2 once every 4 weeks plus weekly intravenous trebananib 15 mg/kg
Trial: 20225606
Drug: Fluorouracil (5-FU)-based
RxNorm normalized name: Fluorouracil
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fluorouracil (5-FU)-based therapy
Trial: 6114885
Drug: Quazepam 15
RxNorm normalized name: quazepam 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quazepam 15 mg capsules
Trial: 31694979
Drug: Oral ondansetron
RxNorm normalized name: Ondansetron
DrugBank: Ondansetron (DB00904)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ondansetron (2 mg for 8-15 kg; 4 mg for >15 kg)
Trial: 10636509
Drug: Hormone replacement
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone replacement therapy (HRT)
Trial: 21359646
Drug: Subcutaneous enoxaparin
RxNorm normalized name: enoxaparin
DrugBank: Enoxaparin (DB01225)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous enoxaparin 40 mg once daily for 10 ± 4 days
Trial: 21150631
Drug: 0.25% bupivacaine
DrugBank: Bupivacaine (DB00297)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 0.25% bupivacaine (0.75 ml kg⁻¹) alone
Trial: 9411906
Drug: Amitriptyline 100
RxNorm normalized name: amitriptyline 100 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline 100 mg
Trial: 22359099
Drug: Polyethylene glycol-electrolyte
RxNorm normalized name: Polyethylene Glycol
DrugBank: Polyethylene glycol (DB09287)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polyethylene glycol-electrolyte solution (PEG)
Trial: 3444801
Drug: Alternate day
RxNorm normalized name: Alternaria alternata
DrugBank: Alternaria alternata (DB10424)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternate day corticosteroid treatment
Trial: 16112244
Drug: Lisinopril plus
RxNorm normalized name: Lisinopril
DrugBank: Lisinopril (DB00722)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lisinopril plus Telmisartan (after 24 weeks of monotherapy for an additional 28 weeks)
Trial: 15312391
Drug: Intravenous chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous chemotherapy only
Trial: 24671488
Drug: Functional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Functional treatment (Tubigrip)
Trial: 12622302
Drug: Routine GP
RxNorm normalized name: carbetapentane citrate / guaifenesin Oral Solution [Pulmari-GP]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine GP treatment + Short-term counselling
Trial: 15362959
Drug: Octreotide acetate
RxNorm normalized name: Octreotide Acetate
DrugBank: Octreotide (DB00104)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Octreotide acetate (Sandostatin LAR 10‐30 mg every 4 weeks i.m.)
Trial: 19453031
Drug: Continuous therapy
RxNorm normalized name: varenicline
DrugBank: Varenicline (DB01273)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuous therapy with omeprazole 10 mg daily (Group A2)
Trial: 19453031
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg daily (Group B)
Trial: 7639224
Drug: 10 U
RxNorm normalized name: vitamin E 10 UNT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 U of recombinant IFN-alpha 2b three times weekly for 24 weeks
Trial: 2562137
Drug: Enalapril 5
RxNorm normalized name: enalapril 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 5 mg/day in addition to previous therapy with digitalis and diuretics
Trial: 2562137
Drug: Continuation of
RxNorm normalized name: varenicline
DrugBank: Varenicline (DB01273)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuation of previous therapy (Control)
Trial: 19710156
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E (182 mg d,l‐alpha‐tocopherol)
Trial: 25452446
Drug: Apricoxib 400
RxNorm normalized name: Apricoxib
DrugBank: Apricoxib (DB12378)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apricoxib 400 mg once per day with docetaxel 75 mg/m2 or pemetrexed 500 mg/m2 once every 21 days
Trial: 9365526
Drug: recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: recombinant human granulocyte-colony stimulating factor (rhG-CSF) administered after the first or second chemotherapy cycle
Trial: 1770154
Drug: Haloperidol 5
RxNorm normalized name: haloperidol 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol 5 mg daily
Trial: 7639807
Drug: Corn oil
RxNorm normalized name: Corn Oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corn oil (9 capsules/day)